[1] Crider KS, Zhu JH, Hao L, et al. MTHFR 677CT genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementationl[J].Am J Clin Nutr, 2011,93:1365–1372.
[2] Natalie J, Colson K, Helen L, et al. The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies[J]. Eur J Nutr, 2017, 56:247–260.
[3] Yang J, Luo G, Chen X.Individualized supplement of folic acid based on the gene polymorphisms of MTHER/MTRR reduced the incidence of adverse pregnancy outcomes and newborn defects[J].Niger J Clin Pract, 2021, 24:1150–1158.
[4] 折开娥,张莉莉,张令燕. 基因检测指导个性化叶酸补充预防新生儿缺陷性疾病效果[J]. 中国计划生育学杂志, 2020, 28: 1254–1257.
[5] Li WX, Dai SX, Zheng JJ, et al. Homocysteine metabolism gene polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) jointly elevate the risk of folate deficiency[J].Nutrients,2015,7:6670–6687.
[6] Quere J, Mercier E, Bellet H, et al. Vitamin supplementation and pregnancy outcome in women with recurrent early pregnancy loss and hyperhomocysteinemia[J].Fertil Steril,2001,75:823–825.
[7] 围受孕期增补叶酸预防神经管缺陷指南工作组. 围受孕期增补叶酸预防神经管缺陷指南(2017)[J].中国生育健康杂志,2017,28:401 –410.
[8] Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial[J].JAMA,2015,313:1325–1335.
[9] 石丽丽,李岩,毛宏梅,等.基因多态性在叶酸干预心脑血管疾病中的作用[J].卫生研究,2023,52:648–656.
[10] Keathley J, Garneau V, Marcil V, et al. Nutrigenetics, omega-3 and plasma lipids/lipoproteins/apolipoproteins with evidence evaluation using the GRADE approach: a systematic review[J].BMJ Open, 2022, 12:e054417.
[11] Keathley J, Garneau V, Marcil V, et al. Clinical practice guidelines using GRADE and AGREE II for the impact of genetic variants on plasma lipid/lipoprotein/apolipoprotein responsiveness to omega-3 fatty acids[J]. Front Nutr,2022, 14:768474.
[12] Vallée Marcotte B, Guénard F, Lemieux S, et al. Fine mapping of genome-wide association study signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid supplementation[J]. Am J Clin Nutr, 2019,109: 176–185.
[13] Mason KE, Palla L, Pearce N, et al. Genetic risk of obesity as a modifier of associations between neighbourhood environment and body mass index: an observational study of 335 046 UK Biobank participants[J]. BMJ Nutr Prev Health, 2020,3:247–255.
[14] Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology[J]. Nature,2015,518:197–206.
[15] Akiyama M, Okada Y, Kanai M, et al. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population[J].Nat Genet,2017,49:1458–1467.
[16] 李岩,陈晨,霍军生.基因多态性在肥胖干预中的作用[J].卫生研究,2023,52:657–665.
[17] Livingstone KM, Celis-morales C, Papandonatos GD, et al. FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials[J].BMJ,2016,354:i4707.
[18] Pinart M, Dotsch A, Schlicht K, et al. Gut Microbiome composition in obese and non-obese persons: a systematic review and meta-analysis[J]. Nutrients, 2021,14:12
[19] 王丽媛,李岩,毛宏梅,等.肠道微生物在肥胖干预中的作用[J].卫生研究,2023,52:666-672.
[20] Cotillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbial gene richness[J]. Nature, 2013, 500: 585–588.
[21] Le CE, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers[J]. Nature, 2013, 500: 541–546.
[22] Costea PI, Hildebrand F, Manimozhiyan A, et al. Enterotypes in the landscape of gut microbial community composition[J]. Nat Microbiol,2018,3:8–16.
[23] Lars C, Stine V, Roager HM, et al. Prevotella abundance predicts weight loss success in healthy, overweight adults consuming a whole-grain diet ad libitum: a post hoc analysis of a 6-wk randomized controlled trial[J]. J Nutr, 2019,149:2174–2181.
[24] Roager HM, Licht TR, Poulsen SK, et al. Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention[J].Int J Obes, 2018, 42:1142–1149.
[25] Xi X, Ma J.A meta-analysis on genetic associations between transcription factor 7 like 2 polymorphisms and type 2 diabetes mellitus[J]. Genomics, 2020, 2: 1192–1196.
[26] 赵珂,李新华,丁文宇.TCF7L2基因单核苷酸多态性与2型糖尿病关系的研究进展[J].山东医药, 2016,56:99–101.
[27] Gjesing AP, Kjems LL, Vestmar MA, et al. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test[J]. Diabetologia, 2011, 54:103–110.
[28] Liu PH, Chang YC, Jiang YD, et al. Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults[J]. J Clin Endocrinol Metab, 2009, 94:3575–3582.
[29] 呼聪慧,苏银霞,阿力米热·阿布迪热依木,等.TCF7L2基因多态性与2型糖尿病的相关性研究[J].医学研究杂志,2023,52:69–72,188.
[30] Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses[J]. Cell,2015, 163: 1079–1094.
[31] Mendes-Soares H, Raveh-Sadka T, Azulay S, et al. Assessment of a personalized approach to predicting postprandial glycemic responses to food among individuals without diabetes[J].JAMA Netw Open,2019,2:e188102.
[32] Marta GF, Adela H, Estefania T, et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis[J]. Diabetes Care, 2016,39: 833–846.
[33] Gar C, Rottenkolber M, Prehn C, et al. Serum and plasma amino acids as markers of prediabetes,insulin resistance,and incident diabetes[J]. Crit Rev Clin Lab Sci, 2018,55: 21–32.
[34] Chen T, Ni Y, Ma X, et al. Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations[J]. Sci Rep, 2016, 6:20594.
[35] Zheng Y, Ceglarek U, Huang T, et al. Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials[J]. Am J Clin Nutr, 2016,103:505–511.
[36] Huang T, Ley SH, Zheng Y, et al. Genetic susceptibility to diabetes and long-term improvement of insulin resistance and β cell function during weight loss: the preventing overweight using novel dietary strategies (POUNDS LOST) trial[J]. Am J Clin Nutr, 2016,104:198–204.
[37] Wang T, Huang T, Zheng Y, et al. Genetic variation of fasting glucose and changes in glycemia in response to 2-year weight-loss diet intervention: the POUNDS LOST trial[J]. Int J Obes (Lond), 2016,40:1164–1169.